Biotage
102.2
SEK
-1.26 %
Less than 1K followers
BIOT
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
-1.26%
-5.98%
-36.44%
-35.76%
-43.94%
-42%
-50%
+21.38%
+3.67%
Biotage operates in the biotechnology industry and focuses on the development and manufacture of products for chemical analysis and preparative chromatography. The company's products are aimed at researchers and laboratories in drug development and food analysis. The business is global with a main presence in Europe, North America and Asia. Biotage was founded in 1987 and is headquartered in Uppsala, Sweden.
Read moreMarket cap
8.27B SEK
Turnover
5.62M SEK
Revenue
2.06B
EBIT %
18.63 %
P/E
28.79
Dividend yield-%
1.61 %
Financial calendar
24/4
2025
Interim report Q1'25
24/4
2025
General meeting '25
25/4
2025
Annual dividend
All
Webcasts
Press releases
ShowingAll content types
Finansinspektionen: Flaggningsmeddelande i Biotage AB

Biotage, Audiocast with teleconference, Q4'24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Biotage AB (publ) Bokslutskommuniké januari-december 2024
Biotage AB (publ) Year end Report January-December 2024
